Zim Laboratories Share Price
Start SIP in Zim Laboratories
Start SIPZim Laboratories Performance
Day Range
- Low 116
- High 120
52 Week Range
- Low 90
- High 131
- Open Price120
- Previous Close118
- Volume284951
Zim Laboratories Investment Rating
-
Master Rating:
-
Zim Laboratories has an operating revenue of Rs. 381.81 Cr. on a trailing 12-month basis. An annual revenue de-growth of -8% needs improvement, Pre-tax margin of 6% is okay, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 15%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 5% and 7% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 10% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 92 which is a GREAT score indicating consistency in earnings, a RS Rating of 34 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 52 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 82 | 117 | 96 | 85 | 67 | 104 |
| Operating Expenses Qtr Cr | 74 | 102 | 85 | 76 | 62 | 89 |
| Operating Profit Qtr Cr | 8 | 15 | 11 | 9 | 5 | 15 |
| Depreciation Qtr Cr | 5 | 4 | 4 | 4 | 4 | 5 |
| Interest Qtr Cr | 3 | 2 | 2 | 1 | 2 | 1 |
| Tax Qtr Cr | 0 | 3 | 2 | 1 | 0 | 3 |
| Net Profit Qtr Cr | 1 | 8 | 5 | 4 | 0 | 7 |
Zim Laboratories Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹115.18
- 50 Day
- ₹112.38
- 100 Day
- ₹110.72
- 200 Day
- ₹109.59
- 20 Day
- ₹113.76
- 50 Day
- ₹111.98
- 100 Day
- ₹110.18
- 200 Day
- ₹109.66
Zim Laboratories Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 123.43 |
| Second Resistance | 128.77 |
| Third Resistance | 131.78 |
| RSI | 55.81 |
| MFI | 88.81 |
| MACD Single Line | 1.69 |
| MACD | 2.26 |
| Support | |
|---|---|
| First Support | 115.08 |
| Second Support | 112.07 |
| Third Supoort | 106.73 |
Zim Laboratories Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 1,009,320 | 51,263,363 | 50.79 |
| Week | 1,130,168 | 75,676,049 | 66.96 |
| 1 Month | 439,272 | 28,104,632 | 63.98 |
| 6 Month | 368,959 | 18,459,031 | 50.03 |
Zim Laboratories Result Highlights
Zim Laboratories Synopsis
NSE-Medical-Generic Drugs
Zim Laboratories is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 365.47 Cr. and Equity Capital is Rs. 48.73 Cr. for the Year ended 31/03/2024. Zim Laboratories Ltd. is a Public Limited Listed company incorporated on 14/02/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1984PLC032172 and registration number is 032172.| Market Cap | 576 |
| Sales | 380 |
| Shares in Float | 3.26 |
| No of funds | 3 |
| Yield |
| Book Value | 2.48 |
| U/D Vol ratio | 1.4 |
| LTDebt / Equity | 15 |
| Alpha | -0.12 |
| Beta | 1.21 |
Zim Laboratories Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 33.26% | 33.26% | 33.26% | 33.26% |
| Foreign Portfolio Investors | 0.01% | |||
| Individual Investors | 49.21% | 49.01% | 50.92% | 50.75% |
| Others | 17.53% | 17.72% | 15.82% | 15.99% |
Zim Laboratories Management
| Name | Designation |
|---|---|
| Dr. Anwar Daud | Chairman & Managing Director |
| Mr. Prakash Sapkal | Director & Head |
| Mr. Niraj Dhadiwal | Director - Business Development |
| Mr. Zulfiquar M Kamal | Director - Finance |
| Dr. Kakasaheb Mahadik | Independent Director |
| Mrs. Kavita Loya | Independent Director |
| Mr. Padmakar Joshi | Independent Director |
| Dr. Kamlesh Shende | Independent Director |
Zim Laboratories Forecast
Price Estimates
Zim Laboratories FAQs
What is Share Price of Zim Laboratories ?
Zim Laboratories share price is ₹119 As on 09 September, 2024 | 16:37
What is the Market Cap of Zim Laboratories ?
The Market Cap of Zim Laboratories is ₹583.2 Cr As on 09 September, 2024 | 16:37
What is the P/E ratio of Zim Laboratories ?
The P/E ratio of Zim Laboratories is 32.6 As on 09 September, 2024 | 16:37
What is the PB ratio of Zim Laboratories ?
The PB ratio of Zim Laboratories is 2.4 As on 09 September, 2024 | 16:37